50.5 EUR
2
3.81%
Last update Dec 17, 9:49 PM CET
Main market
Day range
50.5
56
Previous close
52.5
Open
52.5
Access this stock data via API
Subscribe
Cytokinetics, Incorporated
50.50
2
3.81%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 15.7M 7.5M 94.6M 70.4M
Cost of revenue 289.3M 330.1M 240.8M 159.9M
Gross profit -273.6M -322.6M -146.2M -89.5M
Operating expense
Research & development 159.9M
Selling general and admin 183.6M 173.6M 178.0M 96.8M
Other operating expenses
Operating income -457.1M -496.2M -324.2M -186.3M
Non operating interest income
Income 43.9M 27.6M 11.3M 331K
Expense 73.8M 57.7M 51.2M 29.3M
Other income expense -15.6M -24.9M
Pretax income -502.6M -526.2M -389.0M -215.3M
Tax provision
Net income -502.6M -526.2M -389.0M -215.3M
Basic EPS -5.3 -5.5 -4.3 -2.8
Diluted EPS -5.3 -5.5 -4.3 -2.8
Basic average shares 95.5M 100.3M 92.2M 78.9M
Diluted average shares 95.5M 100.3M 92.2M 78.9M
EBITDA -421.8M -456.7M -307.0M -183.7M
Net income from continuing op. -502.6M -526.2M -389.0M -215.3M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 6 hours 38 minutes

15:21
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).